Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Breast 7 Gastrointestinal 5 Genitourinary 3 CNS 3 Sarcoma 2 Gynecologic 2 Tumor-Agnostic 1 Plasma cell 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Lymphoid 1 Head & Neck 1 Endocrine 1 Dermatologic 1

Conditions

Interventions

pembrolizumab 26 Specimen Handling 17 Blood Specimen Collection 17 Biopsy 16 Magnetic Resonance Spectroscopy 15 atezolizumab 11 Surveys and Questionnaires 11 Bevacizumab 9 Radiotherapy 8 Radiosurgery 8 Nivolumab 8 Fluorouracil 8 Standard of Care 7 Paclitaxel 7 Irinotecan 7 Gemcitabine 7 Cisplatin 7 olaparib 6 durvalumab 6 Palliative Care 6 Oxaliplatin 6 Leucovorin 6 Cyclophosphamide 6 Carboplatin 6 Capecitabine 6 alectinib 5 abemaciclib 5 Trastuzumab 5 Interviews as Topic 5 Exercise 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Genetic Testing × Tumor-Agnostic × Clear all

NCT06008392 2026-04-07

INTERCEPTioN

Mayo Clinic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡